Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check4 days agoChange DetectedNew Study Status history entries were added for dates 2026-03-07 through 2026-03-13, extending the version history with status updates.SummaryDifference0.5%

- Check11 days agoChange DetectedNew history entries were added up to 2026-03-06 and the site revision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.6%

- Check18 days agoChange DetectedNew history entries were added for February 2026, documenting updated Study Status revisions (versions 109–113).SummaryDifference0.5%

- Check25 days agoChange DetectedSeveral new history entries were added, including updates to Study Status across recent versions (from 2026-02-14 to 2026-02-20). This expands the recorded history of the study's status changes.SummaryDifference0.6%

- Check32 days agoChange DetectedThe page history was updated with a new revision (v3.4.2 on 2026-02-12) and removal of an older revision (v3.4.1), affecting only revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page footer now shows a revision update from v3.4.0 to v3.4.1, indicating a small site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.